Emergency order for balversa for patient care
Ended Awarded Last action
- Contract number
- 36C26322N0232
- Awardee
-
Janssen Biotech Inc. UEI NVYMGFA53MN7
- Awarding agency
-
Veterans Integrated Service Network 23
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $11,318
Award facts
- Contract value 100% obligated
- $11,317.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Horsham, PA 19044, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$22,636 | |
| Other Administrative Action | $0 | |
| Original award | $33,954 |
About this award
This federal contract award is for BALVERSA (erdafitinib), an oncology medication, provided by Janssen Biotech Inc. (doing business as Centocor Ortho Biotech Inc.) to the Department of Veterans Affairs (VA). The $11,317.97 firm fixed price contract is a Blanket Purchase Agreement (BPA) call order under Janssen's $3.7 million single-award BPA established in August 2020, which allows VA buying offices to efficiently procure BALVERSA and other oncology drugs. Janssen also holds a $3.1 billion multiple-award Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB) with the VA, which serves as the parent vehicle for many of the company's delivery orders. This emergency order supports continuity of care for veterans undergoing cancer treatment at VA medical facilities across the country. The contract does not have a set-aside designation, reflecting Janssen's status as a large, for-profit pharmaceutical manufacturer.
Quick answers
Who was awarded contract 36C26322N0232?
36C26322N0232 was awarded to Janssen Biotech Inc. by Veterans Integrated Service Network 23 (Veterans Health Administration) on November 9, 2021.
How much is contract 36C26322N0232 worth?
The government has obligated $11,318 on 36C26322N0232.
Is contract 36C26322N0232 an order under another contract?
Yes. 36C26322N0232 is a BPA call under 36F79719D0217-36E79720A0015, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26322N0232 competed?
The extent of competition for 36C26322N0232 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award